Variantyx
Framingham
About Variantyx
Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditional step-wise, reiterative genetic testing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $136.5M
- Funding stage: Late Stage Venture
- Last round: Series D (Apr 2025)
- Website: variantyx.com
- Phone: 617-209-2090
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/variantyx-47725 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.